The company

Urolead is a contract research organization (CRO) that offers preclinical services specialized in the onco-urology sphere (kidney, bladder and prostate cancers).
Spin-off from the Urology Department of the New Civil Hospital of Strasbourg and INSERM, UROLEAD was cofounded in June 2010 by Pr Hervé LANG, urologist, and Dr Thierry MASSFELDER, researcher at INSERM.
Both have many years of experience in onco-urology at clinical, translational and fundamental levels and collaborate  since more than 15 years in this field.

Urolead is now part of Urosphere, a leading CRO company founded in 2004 and specializing in preclinical urology.
Urosphere/ Urolead constitute a unique platform for preclinical research of the urogenital tract with 3 axes :
  • Functional pathologies
  • Pain / inflammation
  • Uro-oncology
Urolead will be integrated in the ISO 9001 quality management certification of Urosphere.